Insulin-like growth-factor-1-induced PKB signaling and Egr-1 expression is inhibited by curcumin in A-10 vascular smooth muscle cells (Q39174244)

9 September 2017

title

Insulin-like growth-factor-1-induced PKB signaling and Egr-1 expression is inhibited by curcumin in A-10 vascular smooth muscle cells (English)

1 reference

9 September 2017

0 references

Viktoria Youreva

1

1 reference

9 September 2017

Georgia Kapakos

series ordinal

2

1 reference

9 September 2017

Ashok K Srivastava

series ordinal

3

1 reference

9 September 2017

publication date

20 December 2012

1 reference

Canadian Journal of Physiology and Pharmacology

9 September 2017

published in

1 reference

9 September 2017

volume

91

1 reference

9 September 2017

issue

3

1 reference

9 September 2017

page(s)

241-247

1 reference

Antioxidant and radical scavenging properties of curcumin

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

The insulin-like growth factor axis: A review of atherosclerosis and restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Curcumin disrupts the Mammalian target of rapamycin-raptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

N-4-tert-butyl benzyl haloperidol chloride suppresses Ca2+-dependent Egr-1 expression and subsequently inhibits vascular smooth muscle cell proliferation induced by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

GSK-3: tricks of the trade for a multi-tasking kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Suppression of growth factor expression and human vascular smooth muscle cell growth by small interfering RNA targeting EGR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Curcumin inhibits renal cyst formation and enlargement in vitro by regulating intracellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Enhanced levels of endogenous endothelin-1 contribute to the over expression of Giα protein in vascular smooth muscle cells from SHR: Role of growth factor receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Glycogen synthase kinase 3 beta positively regulates Notch signaling in vascular smooth muscle cells: role in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Discovery of curcumin, a component of golden spice, and its miraculous biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Aging, atherosclerosis, and IGF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Curcumin inhibits proliferation of human lens epithelial cells: a proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Pharmacology of smooth muscle cell replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Early growth response-1 in cardiovascular pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Pharmacological doses of dietary curcumin increase colon epithelial cell proliferation in vivo in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Role of early growth response 1 in arteriogenesis: impact on vascular cell proliferation and leukocyte recruitment in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Constitutively active glycogen synthase kinase-3beta gene transfer sustains apoptosis, inhibits proliferation of vascular smooth muscle cells, and reduces neointima formation after balloon injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

The insulin-like growth factor family: molecular mechanisms, redox regulation, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Mechano-sensitive transcriptional factor Egr-1 regulates insulin-like growth factor-1 receptor expression and contributes to neointima formation in vein grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

Insulin-like growth factor I and its binding proteins in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0267

21 January 2018

Identifiers

DOI

10.1139/CJPP-2012-0267

1 reference

9 September 2017

1 reference